Cardiovascular physiology of androgens and androgen testosterone therapy in postmenopausal women

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 9, Issue 1, 2009, Pages 29-37

  Ling, Shanhong ^a   Komersaroff, Paul A ^a   Sudhir, Krishnankutty ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; PLACEBO; TESTOSTERONE;

ACNE; ANDROGEN THERAPY; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RESPONSE; CELL FUNCTION; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG DOSE COMPARISON; ENDOTHELIUM CELL; FEMALE; HIRSUTISM; HORMONE ACTION; HUMAN; HYPERANDROGENISM; METABOLIC SYNDROME X; NONHUMAN; POSTMENOPAUSE; PREMENOPAUSE; REVIEW; SIDE EFFECT; TESTOSTERONE METABOLISM; VASCULAR ENDOTHELIUM; VIRILIZATION; ANIMAL; CARDIOVASCULAR SYSTEM; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; MACROPHAGE; PHYSIOLOGY;

ANDROGENS; ANIMALS; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; ENDOTHELIAL CELLS; FEMALE; HUMANS; MACROPHAGES; METABOLIC SYNDROME X; POSTMENOPAUSE; TESTOSTERONE;

EID: 65549112993     PISSN: 18715303     EISSN: None     Source Type: Journal    
DOI: 10.2174/187153009787582414     Document Type: Review

References (75)

1. Hulley, S.; Grady, D.; Bush, T.; Furberg, C.; Herrington, D.; Riggs, B. and Vittinghoff, E. (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA, 280, 605-613.
2. Writing Group for Women's Health Initiative Investigators. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA, 288, 321-333.
3. Turner, H. and Wass, J. (1997) Declining gonadal function in men with chronic disease. Clin. Endocronol., 47, 379-403.
4. Dunaif A. (1993) Insulin resistance in polycystic ovarian syndrome. Ann. N Y Acad. Sci., 687, 60-64.
5. Liu, Y.; Ding, J.; Bush, T.L.; Longenecker, J.C.; Nieto, F.J.; Golden, S.H. and Szklo, M. (2001) Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation. Am. J. Epidemiol., 154, 489-494.
6. Overlie, I.; Moen, M.H.; Morkrid, L.; Skjaeraasen, J.S. and Holte, A. (1999) The endocrine transition around menopause - a five year prospective study with profiles of gonadotropins, estrogens, androgens and SHBG among healthy women. Acta. Obstet. Gynecol. Scand., 78, 642-647.
7. Alexandra, J.; Dennerstein, L.; Burger, H. and Graziottin, A. (2006) Testosterone and libido in surgically and naturally menopausal women. Women's Health, 2, 459-477.
8. Montalcini, T.; Gorgone, G.; Gazzaruso, C.; Sesti, G.; Perticone, F. and Pujia, A. (2007) Role of endogenous androgens on carotid atheroslcerosis in non-obese postmenopausal women. Nutr. Metab. Cardiovasc. Dis., 17, 705-711.
9. Adashi, E.Y. (1994) The climacteric ovary as a functional gonadotropin-driven androgen-producing gland. Fertil. Steril., 62, 20-27.
10. Arlt, W.; Justl, H.G.; Callies, F.; Feincke, M.; Hubler, D.; Oettel, M.; Ernst, M.; Schulte, H.M. and Allolio, B. (1998) Oral dehydroepiandrosterone for adrenal androgen replacement: Pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy female after dexamethasone suppression. J. Clin. Endocrinol. Metab., 83, 1928-1934.
11. Zumoff, B.; Strain, G.W.; Miller, L.K. and Rosner, W. (1995) Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J. Clin. Endocrinol. Metab., 80, 1429-1430.
12. Burger, H.G.; Dudley, E.C.; Cui, J.; Demerstein, L. and Hopper, J.L. (2000) A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J. Clin. Endocrinol. Metab., 85, 2832-2838.
13. Davison, S.L.; Bell, R.; Donath, S.; Montalto, J.G. and Davis, S.R. (2005) Androgen levels in adult females: changes with age, menopause, and oophorectomy. J. Clin. Endocrinal. Metab., 90, 3847-3853.
14. Fujimoto, R.; Morimoto, I.; Morita, E.; Sugimoto, H.; Ito, Y. and Eto, S. (1994) Androgen receptor, 5α-reductase activity and androgen-dependent proliferation of vascular smooth muscle cells. J. Steroid Biochem. Mol. Biol., 50, 169-174.
15. Bayard, F.; Clamens, S.; Meggetto, F.; Blaes, N.; Delsol, G. and Faye, J.C. (1995) Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology, 136, 1523-1529.
16. Lin, A.L.; Schultz, J.J.; Brenner, R.M. and Shain, S.A. (1990) Sexual dimorphism characterize baboon myocardial androgen receptors. J. Steroid Biochem. Mol. Biol., 37, 85-95.
17. Knauthe, R.; Diel, P.; Hegele-Hartung, C.; Engelhaupt, A. and Fritzemeier, K.H. (1996) Sexual dimorphism of steroid hormone receptor messenger ribonucleic acid expression and hormonal regulation in rat vascular tissue. Endocrinology, 137, 3220-3227.
18. Heinlein, C.A. and Chang, C. (2002) Androgen receptor (AR) coregulators: an overview. Endocr. Rev., 23, 175-200.
19. Heinlein, C.A. and Chang, C. (2002) The role of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol. Endocrinol., 16, 2181-2187.
20. English, K.M.; Jones, R.D.; Jones, T.H.; Morice, A.H. and Channer, K.S. (2002) Testosterone acts as a coronary vasodilator by a calcium antagonistic action. J. Endocrinol. Invest., 25, 455-458.
21. Raitakari, O.T. and Celermajar, D.S. (2000) Flow-mediated dilatation. Br. J. Clin. Pharmacol., 50, 397-404.
22. Hashimoto, M.; Akishita, M.; Eto, M.; Ishikawa, M.; Kozaki, K.; Toba, K.; Sagara, Y.; Taketani, Y.; Orimo, H. and Ouchi, Y. (1995) Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation, 92, 3431-3435.
23. Celermajar, D.S.; Sorensen, K.E.; Spiegelhalter, D.J.; Georgakopoulos, D.; Robinson, J. and Deanfield, J.E. (1994) Aging is associated with endothelial dysfunction in healthy men years before age-related decline in women. J. Am. Coll. Cardiol., 24, 471-476.
24. Sader, M.A. and Celermajer, D.S. (2002) Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovasc. Res., 53, 597-604.
25. McCredie, R.J.; McCrohon, J.A.; Turmer, L.; Griffiths, K.A.; Handelsman, D.J. and Celemajar, D.S. (1998) Vascular reactivity is impaired in genetic females taking high dose androgens. J. Am. Coll. Cardiol., 32, 1331-1335.
26. Worboys, S.; Kotsopoulos, D.; Teede, H.; McGrath, B. and Davis, S.R. (2001) Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen. J. Clin. Endocrinol. Metab., 86, 158-161.
27. Williams, M.R.; Dawood, T.; Ling, S.; Dai, A.; Lew, R.; Myles, K.; Funder, J.W.; Sudhir, K. and Komesaroff, P.A. (2004) Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. J. Clin. Endocrinol. Metab., 89, 4708-4715.
28. Holm, P.; Andersen, H.L.; Arroe, G. and Stender, S. (1998) Gender gap in aortic cholesterol accumulation in cholesterol-clamped rabbits: role of the endothelium and mononuclear-endothelial cell interaction. Circulation, 98, 2731-2737.
29. Ross, R. (1999) Atherosclerosis - an inflammatory disease. N. Engl. J. Med., 340, 115-126.
30. McCrohon, J.A.; Jessup, W.; Handelsman, D.J. and Celermajer, D.S. (1999) Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation, 99, 2317-2322.
31. Zhang, X.; Wang, L.Y.; Jiang, T.Y.; Zhang, H.P.; Dou, Y.; Zhao, J.H.; Zhao, H.; Qiao, Z.D. and Qiao, J.T. (2002) Effects of testosterone and 17-beta-estradiol on TNF-alpha-induced E-selectin and VCAM-1 expression in endothelial cells. Analysis of the underlying receptor pathways. Life Sci., 71, 15-29.
32. Mukherjee, T.K.; Dinh, H.; Chaudhuri, G. and Nathan, L. (2002) Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis. Proc. Natl. Acad. Sci. USA, 99, 4055-4060.
33. Ling, S.; Dai, A.; Williams, M.R.; Myles, K.; Dilley, R.J.; Komesaroff, P.A. and Sudhir, K. (2002) Testosterone (T) enhances apoptosis-related damage in human vascular endothelial cells. Endocrinology, 143, 1119-1125.
34. Liu, D.; Si, H.; Reynolds, K.A.; Zhen, W.; Jia, Z. and Dillon, J.S. (2007) Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression. Endocrinology, 148, 3068-3076.
35. Akishita, M.; Ouchi, Y.; Miyoshi, H.; Kozaki, K.; Inoue, S.; Ishikawa, M.; Eto, M.; Toba, K. and Orimo, H. (1997) Estrogen inhibits cuff-induced intimal thickening of rat female artery: effects on migration and proliferation of vascular smooth muscle cells. Atherosclerosis, 130, 1-10.
36. Chen, S.J.; Li, H.; Durand, J.; Oparil, S. and Chen, Y.F. (1996) Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation, 93, 577-584.
37. McCrohon, J.A.; Death, A.K.; Nakhla, A.; Jessup, W.; Handelsman, D.J.; Stanley, K.K. and Celermajer, D.S. (2002) Androgen receptor expression is greater in macrophages from male than from female donors. A sex difference with implications for atherosclerosis. Circulation, 101, 224-226.
38. Langer, C.; Gansz, B.; Goepfert, C.; Engel, T.; Uehara, Y.; von Dehn, G.; Jansen, H.; Assmann, G. and von Eckardstein, A. (2002) Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages. Biochem. Biophys. Res. Commun., 296, 1051-1057.
39. Fluiter, K.; van der Westhuijzen, D.R. and Van Berkel, T.J. (1998) In vivo regulation of scavenger receptor B1 and the selective uptake of high density lipoprotein cholesterol esters in rat liver parenchymal and Kupffer cells. J. Biol. Chem., 273, 8434-8438.
40. Benten, W.P.; Lieberherr, M.; Stamm, O.; Wrehlke, C.; Guo, Z. and Wunderlich, F. (1999) Testosterone signalling through internalizable surface receptors in androgen receptor-free macrophages. Mol. Biol. Cell, 10, 3113-3123.
41. Friedl, R.; Brunner, M.T. and Spieckermann, P.G. (2000) Testosterone inhibits expression of inducible nitride oxide synthesis in murine macrophages. Life Sci., 68, 417-429.
42. Nahrendorf, M.; Frantz, S.; Hu, K.; von zur Muhlen, C.; Tomaszewski, M.; Scheuermann, H.; Karser, R.; Jazbutyte, V.; Beer, S.; Bauer, W.; Neubauer, S.; Ertl, G.; Allolio, B. and Collies, F. (2003) Effects of testosterone on post-myocardial infarction remodelling and function. Cardiovasc. Res., 57, 370-378.
43. Cavasin, M.A.; Sankey, S.S.; Yu, A.L.; Menon, S. and Yang, X.P. (2003) Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am. J. Physiol. Heart Circ. Physiol., 284, H1560-H1569.
44. Thum, T. and Borlak, J. (2002) Testosterone, cytochrome P450, and cardiac hypertrophy. FASEB, 16, 1537-1545.
45. Vicencio, J.M.; Ibarra, C.; Estrada, M.; Chiong, M.; Soto, D.; Parra, V.; Diaz-Araya, G.; Jaimovich, E. and Lavandero, S. (2006) Testosterone induces an intracellular calcium increase by a nongenomic mechanism in cultured rat cardiac myocytes. Endocrinology, 147, 1386-1395.
46. Reckelhoff, J.F.; Zhang, H. and Granger, J.P. (1998) Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension, 31, 435-439.
47. Hinojosa-Laborde, C.; Lange, D.L. and Haywood, J.R. (2000) Role of female sex hormones in the development and reversal of dahl hypertension. Hypertension, 35(1 Pt 2), 484-489.
48. Crofton, J.T. and Share, L. (1997) Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats. Hypertension, 29, 494-499.
49. Wiinber, N.; Hoegholm, A.; Christensen, H.; Bang, L.; Mikkelsen, K.; Nielsen, P.; Svendsen, T.; Kampmann, J.; Madsen, N. and Bentzon, M. (1995) 24-h Ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am. J. Hypertens., 8, 978-986.
50. Burl, V.L.; Whelton, P.; Roccella, E.J.; Brown, C.; Cutler, J.A.; Higgins, M.; Horan, M.J. and Labarthe, D. (1995) Prevalence of hypertension in the US adult population. Results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension, 25, 305-313.
51. Turner, H. and Wass, J. (1997) Declining gonadal function in men with chronic disease. Clin. Endocrinol., 47, 379-403.
52. Oh, J.Y.; Barrett-Connor, E.; Wedick, N.M.; Wingard, D.L. and Rancho Bernardo Study. (2002) Endogenous sex hormones and the development of type 2 diabetes in old men and women: The Rancho Bernardo Study. Diabetes Care, 25, 55-60.
53. Polderman, K.H.; Gooren, L.J.; Asscheman, H.; Bakker, A. and Heine, R.J. (1994) Induction of insulin resistance by androgens and estrogens. J. Clin. Endocrinol. Metab., 79, 265-271.
54. Diamond, M.P.; Grainger, D.; Diamond, M.C.; Sherwin, R.S. and Defronzo, R.A. (1998) Effects of methyltestosterone on insulin secretion and sensitivity in women. J. Clin. Endocrinol. Metab., 83, 4420-4425.
55. Philips, G.B.; Tuck, C.H.; Jing, T.Y.; Boden-Albala, B.; Lin, I.F.; Dahodwala, N. and Sacco, R.L. (2000) Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women. Diabetes Care, 23, 74-79.
56. Kumagai, S.; Kai, Y. and Sasaki, H. (2001) Relationship between insulin resistance, sex hormones and sex hormone-binding globulin in the serum lipid and lipoprotein profiles of Japanese postmenopausal women. J. Atheroscler. Thromb., 8, 14-20.
57. Golden, S.H.; Ding, J.; Szklo, M.; Schmidt, M.I.; Duncan, B.B. and Dobs, A. (2004) Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women. The atherosclerosis risk in communities study. Am. J. Epidemiol., 160, 540-548.
58. Rincon, J.; Holmang, A.; Wahlstrom, E.O.; Lönnroth, P.; Björntorp, P.; Zierath, J.R. and Wallberg-Henriksson, H. (1996) Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes, 45, 615-621.
59. Leao, L.C.; Durate, M.P.; Silva, D.M.; Bahia, P.R.; Coeli, C.M. and Farias, M.L.F. (2006) Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study. Eur. J. Endocrinol., 154, 131-139.
60. Weidemann, W. and Hanke, H. (2002) Cardiovascular effects of androgens. Cardiovasc. Drug Rev., 20, 175-198.
61. Birdsall, M.A.; Farquhar, C.M. and White, H.D. (1997) Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann. Intern. Med., 126, 32-35.
62. Wild, S.; Pierpoint, T.; McKeigue, P. and Jacobs, H. (2002) Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin. Endocrinol. (Oxf)., 52, 595-600.
63. Obasanjo, I.O.; Clarkson, T.B. and Weaver, D.S. (1996) Effects of the anabolic steroid nondrolone decanoate on plasma lipids and coronary arteries of female cynomolgus macaques. Metabolism, 45, 463-468.
64. Adams, M.R.; Williams, J.K. and Kaplan, J.R. (1995) Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler. Thromb. Vasc. Biol., 15, 562-570.
65. Labrie, F.; Belarger, A.; Cusan, L. and Candas, B. (1997) Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites. J. Clin. Endocrinol. Metab., 82, 2403-2409.
66. Mazer, N.A. and Shifren, J.L. (2003) Transdermal testosterone for women: a new physiological approach for androgen therapy. Obstet. Gynecol. Surv., 58, 489-500.
67. Shifren, J.L.; Braunstein, G.D.; Simon, J.A.; Casson, P.R.; Buster, J.E.; Redmond, G.P.; Burki, R.E.; Ginsburg, E.S.; Rosen, R.C.; Leiblum, S.R.; Caramelli, K.E. and Mazer, N.A. (2000) Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N. Engl. J. Med., 343, 682-688.
68. Buster, J.E.; Kingsberg, E.S.; Aguirre, O.A.; Brown, C.; Beaux, J.G.; Buch, A.; Rodenberg, C.A.; Wekselman, K. and Casson, P. (2005) Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obster. Gynecol., 105, 944-952.
69. Braunstein, G.D.; Sundwell, D.A.; Katz, M.; Shifren, J.L.; Buster, J.E.; Simon, J.A.; Bachman, G.; Aguirre, O.A.; Lucas, J.D.; Rodenberg, C.A.; Buch, A. and Watts, N.B. (2005) Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch. Intern. Med., 165, 1582-1589.
70. Simon, J.A.; Braunstein, G.D.; Nachtigall, L.; Utina, W.; Katz, M.; Miller, S.; Waldbaum, A.; Bouchard, C.; derzko, C.; Buch, A.; Rodenberg, C.A.; Lucas, J.D. and Davis, S. (2005) Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J. Clin. Endocrinol. Metab., 90, 5226-5233.
71. Secreto, G.; Toniolo, P.; Berrino, F.; Recchione, C.; Cavalleri, A.; Pisani, P.; Totis, A.; Fariselli, G. and Di Pietro, S. (1991) Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res., 51, 2572-2576.
72. Braunstein, G.D. (2007) Safety of testosterone treatment in postmenopausal women. Fertil. Steril., 88, 1-17.
73. Somboonpom, W. and Davis, S.R. (2004) Testosterone effects on the breast: implications for testosterone therapy for women. Endocr. Rev., 25, 374-388.
74. Dimitrakakis, C.; Zhou, J. and Bondy, C.A. (2002) Androgens and mammary growth and neoplasia. Fertil. Steril., 77, S26-S33.
75. Laughlin, G.A.; Barrett-Connor, E.; Kritz-silverstein, D. and von Muhlen, D. (2000) Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab., 85, 645-651.